In-vivo phenotyping for CYP3A by a single-point determination of midazolam plasma concentration-Reference-Cited by-同舟云学术

In-vivo phenotyping for CYP3A by a single-point determination of midazolam plasma concentration

Published:2001-12 Issue:9 Volume:11 Page:781-791
ISSN:0960-314X
Container-title:Pharmacogenetics
language:en
Short-container-title:Pharmacogenetics

Author:

Lin Yvonne S.,Lockwood Graham F.,Graham Martin A.,Brian William R.,Loi Cho-Ming,Dobrinska Michael R.,Shen Danny D.,Watkins Paul B.,Wilkinson Grant R.,Kharasch Evan D.,Thummel Kenneth E.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Pharmacology, Toxicology and Pharmaceutics,Genetics

Reference31 articles.

1. CYTOCHROME P-450 3A4: Regulation and Role in Drug Metabolism

2. cDNA Cloning and Initial Characterization of CYP3A43, a Novel Human Cytochrome P450

3. The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons

4. IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3A

5. CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: Evidence for an allelic variant with altered catalytic activity

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intrasubject Variability in Intravenous and Oral Probes for Hepatic and First-Pass CYP3A Activity;Clinical Pharmacokinetics;2024-07-29

2. Pharmacokinetics, Pharmacodynamics, and Side Effects of Midazolam: A Review and Case Example;Pharmaceuticals;2024-04-08

3. Differences of Atomic-Level Interactions between Midazolam and Two CYP Isoforms 3A4 and 3A5;Molecules;2023-10-01

4. Lean Body Mass and Total Body Weight Versus Body Surface Area as a Determinant of Docetaxel Pharmacokinetics and Toxicity;Therapeutic Drug Monitoring;2022-12

5. Characterization of Cytochrome P450 Mechanism Based Inhibition;Drug Metabolism Handbook;2022-11-18